The results showed higher YTHDF3 protein expression levels in primary breast cancer, HCC, ovarian cancer, colon cancer, UCEC, and LUAD tissues compared with normal tissues (Figure 1B, P < 0.001). This evidence concerns the gene YTHDF3 and breast carcinoma.